Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 1/20 | 0.62 |
| ▸ | ACHE | P22303 | 6/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.35 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.35 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22859167 | 0.92 | NCF1 (0.54) | NCF1ACHEHRH3HRH4GNAI3 | |
| SCHEMBL25565871 | 0.92 | NCF1 (0.54) | NCF1ACHEHRH3HRH4GNAI3 | |
| SCHEMBL25566048 | 0.92 | NCF1 (0.54) | NCF1ACHEHRH3HRH4GNAI3 | |
| SCHEMBL8363126 | 0.89 | NCF1 (0.52) | NCF1ACHEHRH3HRH4CYP1A2 | |
| SCHEMBL27267695 | 0.89 | NCF1 (0.52) | NCF1ACHEHRH3HRH4GNAI3 | |
| SCHEMBL26003984 | 0.87 | NCF1 (0.50) | NCF1ACHEHRH3HRH4GNAI3 | |
| SCHEMBL21078340 | 0.87 | NCF1 (0.50) | NCF1ACHEHRH3HRH4CYP2D6 | |
| SCHEMBL24881447 | 0.85 | NCF1 (0.48) | NCF1ACHEHRH3HRH4GNAI3 | |
| SCHEMBL21440443 | 0.85 | NCF1 (0.48) | NCF1ACHEHRH3HRH4GNAI3 | |
| SCHEMBL4036508 | 0.85 | NCF1 (0.48) | NCF1ACHEHRH3HRH4GNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720172-A1 | SIDE-CHAIN FUNCTIONALIZED POLYNORBORNENES AS IONOMERS AND AS MEMBRANE MATERIALS FOR ALKALINE ELECTROLYSIS OF WATER, AND FUEL CELL | Forschungszentrum Jülich GmbH (DE) | 2026-04-08 | — | — | EP | disclosed |
| WO-2025242796-A1 | HYDROGENATED SIDE-CHAIN FUNCTIONALIZED POLYNORBORNENE-ANION EXCHANGE POLYMERS AS MEMBRANE MATERIALS FOR ALKALINE WATER ELECTROLYSIS AND FUEL CELLS | Forschungszentrum Jülich GmbH (DE) | 2025-11-27 | — | — | WO | disclosed |
| WO-2024245731-A1 | SIDE-CHAIN FUNCTIONALIZED POLYNORBORNENES AS IONOMERS AND AS MEMBRANE MATERIALS FOR ALKALINE ELECTROLYSIS OF WATER, AND FUEL CELL | Forschungszentrum Jülich GmbH (DE) | 2024-12-05 | — | — | WO | disclosed |
| WO-2024112692-A1 | CASITAS B-LINEAGE LYMPHOMA PROTOONCOGENE B (CBL-B) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE | ARVINAS OPERATIONS, INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| US-20230167118-A1 | DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INIDBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE | BEONE MEDICINES I GMBH (CH) | 2023-06-01 | — | — | US | disclosed |
| US-20230167118-A1 | DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INIDBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE | BEONE MEDICINES I GMBH (CH) | 2023-06-01 | — | — | US | disclosed |
| WO-2022047145-A1 | RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE | ARVINAS OPERATIONS, INC. (US) | 2022-03-03 | — | — | WO | disclosed |
| US-20210317134-A1 | UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF | RAPT THERAPEUTICS INC (US) | 2021-10-14 | — | — | US | disclosed |
| US-20180111900-A1 | WATER SOLUBLE CHAIN TRANSFER AGENTS | THE LUBRIZOL CORPORATION | 2018-04-26 | — | — | US | disclosed |
| US-9909119-B2 | Method for producing purified soybean oligosaccharide liquid | TORAY INDUSTRIES, INC. (JP) | 2018-03-06 | — | — | US | disclosed |
| US-20090274840-A1 | INK JET INK, INK SET, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT AND INK JET RECORDING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2009-11-05 | — | — | US | disclosed |
| US-20090238975-A1 | INK JET INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT AND INK JET RECORDING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2009-09-24 | — | — | US | disclosed |
| US-7557235-B2 | Hydroxyl-terminated thiocarbonate containing compounds, polymers, and copolymers, and polyurethanes and urethane acrylics made therefrom | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2009-07-07 | — | — | US | disclosed |
| US-7495050-B2 | Associative thickeners for aqueous systems | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2009-02-24 | — | — | US | disclosed |
| US-7423082-B2 | Associative thickeners for aqueous systems | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2008-09-09 | — | — | US | disclosed |
| US-20080214773-A1 | S-(Alpha, Alpha'-Disubstituted-Alpha\"-Acetic Acid) - Substituted Dithiocarbonate Derivatives For Controlled Radical Polymerizations, Process and Polymers Made Therefrom | LAI JOHN TA-YUAN | 2008-09-04 | — | — | US | disclosed |
| US-20080153982-A1 | Vinyl-Thiocarbonate and Polyol Containing Block Copolymers | LUBRIZOL ADVANCED MATERIALS, INC. | 2008-06-26 | — | — | US | disclosed |
| US-20080153982-A1 | Vinyl-Thiocarbonate and Polyol Containing Block Copolymers | LUBRIZOL ADVANCED MATERIALS, INC. | 2008-06-26 | — | — | US | disclosed |
| US-20080050995-A1 | Hydroxyl-Terminated Thiocarbonate Containing Compounds, Polymers, and Copolymers, and Polyurethanes and Urethane Acrylics Made Therefrom | LUBRIZOL ADVANCED MATERIALS, INC. | 2008-02-28 | — | — | US | disclosed |
| US-7335788-B2 | S-(α, α′-disubstituted-α″-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2008-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180111900-A1 | WATER SOLUBLE CHAIN TRANSFER AGENTS | TRRAP, FUS, TNKS | NCF1 960/4885ACHE 4740/4885HRH3 4647/4885 |
| US-20230167118-A1 | DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INIDBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE | BTK, CBL, SYK | NCF1 1718/4885ACHE 3370/4885HRH3 3357/4885 |
| US-20210317134-A1 | UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF | USP7, SENP7, USP8 | NCF1 2934/4885ACHE 2101/4885HRH3 3170/4885 |
| US-20080214773-A1 | S-(Alpha, Alpha'-Disubstituted-Alpha\"-Acetic Acid) - Substituted Dithiocarbonate Derivatives For Controlled Radical Polymerizations, Process and Polymers Made Therefrom | TST, ACMSD, ETFA | NCF1 2014/4885ACHE 2018/4885HRH3 4760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.